SCHEMBL8665490

SCHEMBL8665490

CCCCc1c(N2CCC(NC(=O)c3ccccc3)C2=O)ccc2c1C(C(=O)NCC(F)(F)F)c1ccccc1-2

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FPR1 P21462 19/20 0.39
▸ FPR2 P25090 19/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8668022 0.90 FPR1 (0.36) FPR1FPR2
SCHEMBL8665881 0.84 DRD2 (0.37) —
SCHEMBL8501237 0.84 MTTP (0.36) —
SCHEMBL8666097 0.82 DRD2 (0.36) —
SCHEMBL8501050 0.82 MTTP (0.36) —
SCHEMBL8500999 0.80 CTSL (0.37) —
SCHEMBL8593680 0.80 POLB (0.42) —
SCHEMBL8572056 0.77 NR2E1 (0.33) —
SCHEMBL8665488 0.77 CCR2 (0.37) FPR1FPR2
SCHEMBL8574487 0.77 POLB (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827875-A PYRROLIDINE DERIVATIVES; ANTIATHEROSCLEROSIS AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-10-27 — — US claimed
Send feedback